Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Pescovitz

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Diabetes|June 13, 2012
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet dataCarla J Greenbaum, Craig A Beam, David Boulware, et al.
Diabetes Care|September 13, 2013
B-lymphocyte depletion with rituximab and β-cell function: two-year resultsMark D Pescovitz, Carla J Greenbaum, Brian Bundy, et al.
The New England Journal of Medicine|November 27, 2009
Rituximab, B-lymphocyte depletion, and preservation of beta-cell functionMark D Pescovitz, Carla J Greenbaum, Heidi Krause-Steinrauf, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Diabetes|June 13, 2012
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet dataCarla J Greenbaum, Craig A Beam, David Boulware, et al.
Diabetes Care|September 13, 2013
B-lymphocyte depletion with rituximab and β-cell function: two-year resultsMark D Pescovitz, Carla J Greenbaum, Brian Bundy, et al.
The New England Journal of Medicine|November 27, 2009
Rituximab, B-lymphocyte depletion, and preservation of beta-cell functionMark D Pescovitz, Carla J Greenbaum, Heidi Krause-Steinrauf, et al.
Pageof 7